Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

Neurocrine Biosciences and Sosei Heptares Announce Collaboration to Develop Novel Muscarinic Receptor Agonists for Schizophrenia and Other Neuropsychiatric Disorders

Read more

Twist Bioscience Enters into Definitive Agreement to Acquire Abveris, Bolstering Biopharma Capabilities

Read more

Obseva Announces U.S. FDA Acceptance of New Drug Application for Linzagolix

Read more

Vifor Pharma to spearhead development of vascular calcification field, through acquisition of Sanifit Therapeutics and Inositec AG

Read more

REGENXBIO Announces Orphan Drug Designation Granted to RGX-202, a Novel Gene Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy

Read more

Arrowhead Pharmaceuticals Enters Exclusive License Agreement with GSK for ARO-HSD

Read more

Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor

Read more

CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China

Read more

Gilead Exercises Options to Three Arcus Biosciences Clinical-stage Programs and Adds Research Collaboration

Read more

Novo Nordisk to acquire Dicerna Pharmaceuticals including the RNAi research technology platform

Read more

Posts pagination

Previous Page 1 of 957 … Page 343 of 957 … Page 957 of 957 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version